JCOGの基本情報 > 研究実績 > 肺がん外科グループ

JCOGの基本情報肺がん外科グループ

更新日:2018年9月6日

  1. 論文
    1. 委員会承認の治療研究
      JCOG8601
      M Ohta, R Tsuchiya, M Shimoyama, et al.: Adjuvant Chemotherapy for Completely Resected Stage III Non-small-cell Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery. 106(4): 703-708, 1993.
      JCOG 9101
      R Tsuchiya, K Suzuki, Y Ichinose, et al.: Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg. 129(5): 977-983, 2005.
      JCOG9209
      K Nagai, R Tsuchiya, et al.: A Randomized Trial Comparing Induction Chemotherapy Followed by Surgery with Surgery Alone for Patients with Stage ⅢA N2 Non-Small Cell Lung Cancer (JCOG 9209). J Thorac Cardiovasc Surg. 125(2): 253-260, 2003.
      JCOG 9304
      H Tada, R Tsuchiya, Y Ichinose, et al.: A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43(2): 167-173, 2004.
      JCOG 9606
      H Kunitoh, T Tamura, T Shibata, et al. and JCOG Lung Cancer Study Group: A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606). Br J Cancer. 29;103(1):6-11, 2010.
      JCOG 9806
      H Kunitoh, H Kato, M Tsuboi, et al. and Japan Clinical Oncology Group: Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol. 1;26(4):644-649, 2008. Erratum in: J Clin Oncol. 20; 29, 2011.
      JCOG 0201
      H Asamura, T Hishida, K Suzuki, et al. and Japan Clinical Oncology Group Lung Cancer Surgical Study Group: Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg. 146(1):24-30, 2013.
      K Suzuki. and JCOG Lung Cancer Surgical Group: JCOG0201 defined "radiological early peripheral lung adenocarcinoma". J Thorac Oncol. 6(8):1452-1453, 2011.
      K Suzuki, T Koike, T Asakawa, et al. and Japan Lung Cancer Surgical Study Group (JCOG LCSSG): A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 6(4):751-756, 2011.
      JCOG 0204
      H Kunitoh, H Kato, M Tsuboi, et al. and JCOG Lung Cancer Surgical Study Group: A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204). Br J Cancer. 16;99(6): 852-857, 2008.
      JCOG 0802
      K Nakamura, H Saji, R Nakajima, et al.: A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 40(3): 271-274, 2010.
      JCOG 0804
      K Suzuki, S Watanabe, J Mizusawa, et al. and Japan Lung Cancer Surgical Study Group (JCOG LCSSG): Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study. Interact Cardiovasc Thorac Surg. 21(2): 218-223, 2015.
      JCOG 1205
      J Eba, H Kenmotsu, M Tsuboi, et al. and Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group; Lung Cancer Study Group of the Japan Clinical Oncology Group: A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). Jpn J Clin Oncol. 44(4): 379-382, 2014.
      JCOG1313-A(JCOG0201 とJCOG0403 の統合解析)
      J Eba, K Nakamura, J Mizusawa, et al.: Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). Jpn J Clin Oncol. 46(8): 748-753, 2016.
      JCOG1211
      K Aokage, H Saji, K Suzuki, et al.: A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg. 65(5): 267-272, 2017.
      JCOG1413
      T Hishida, H Saji, S Watanabe, et al.: A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413). Jpn J Clin Oncol. 1;48(2): 190-194, 2018.
    2. グループ代表者管理の治療研究
      • K Yokoi, R Tsuchiya, et al.: Results of surgical treatment of lung cancer involving the diaphragm. J Thorac Cardiovasc Surg. 120(4): 799-805, 2000.
      • M Sagawa, T Koike, M Sato, et al.: Segmentectomy for roentgenographically occult bronchogenic squamous cell carcinoma. Ann Thorac Surg. 71: 1100-1104, 2001.
      • Y Ichinose, H Kato, T Koike, et al. and the Japan Clinical Oncology Group: Overall Survival and Local Recurrence of 406 Completely Resected Stage IIIa-N2 Non-Small Cell Lung Cancer Patients: Questionnaire Survey of the Japan Clinical Oncology Group to Plan for Clinical Trials. Lung Cancer. 34: 29-36, 2001.
      • Y Ichinose, H Kato, T Koike, et al. and The Japan Clinical Oncology Group: Completely Resected Stage IIIA Non-Small Cell Lung Cancer: The significance of Primary Tumor Location and N2 Station. J Thorac Cardiovasc Surg. 122: 803-808, 2001.
      • C Endo, Y Saito, T Kondo, et al.: A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer. 40: 181-186, 2003.
      • H Kato, Y Ichinose, et al.: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 350(17): 1713-1721, 2004.
      • M Tsuboi, H Kato, K Nagai, et al.: Gefitinib in the adjuvant setting: safety results from a phase III study in patients with completely resected non-small cell lung cancer. Anticancer Drugs. 16(10): 1123-1128, 2005.
      • T Hishida, K Nagai, T Mitsudomi, et al. and Japan Clinical Oncology Group: Salvage surgery for advanced non-small cell lung cancer after response to gefitinib. J Thorac Cardiovasc Surg. 140(5): e69-71, 2010.
      • H Asamura, S Watanabe: In response to the review article in Surgery Today: JCOG trials for small adenocarcinomas of the lung. Surg Today. 44(8):1593-1594, 2014.
      • T Hishida, M Tsuboi, T Shukuya, et al.: Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6). Jpn J Clin Oncol. 45(5): 499-501, 2015.
    3. 附随研究等
      • H Asamura, H Nakayama, H Kondo, et al.: Is lymph node dissection necessary in small, non-small-cell carcinoma of the lung occurring at the peripheral region? Nippon Kyobu Geka Gakkai Zasshi. 45(3): 365-366, 1997
      • T Yano, Y Fukuyama, H Yokoyama, et al.: Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systemic mediastinal node dissection. Eur J Cardio-thorac Surgery. 14: 152-155, 1998.
      • T Kondo, M Sagawa, T Tanita, et al.: Is complete systematic nodal dissection by thoracoscopic surgery possible? ? a prospective trial of video-assisted lobectomy for cancer of the right lung. J Thorac Cardiovasc Surg. 116: 651-652, 1998.
      • C Endo, M Sagawa, M Sato, et al.: What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent?: retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squamous cell carcinoma. Lung Cancer. 21: 93-97, 1998.
      • K Inoue, M Sato, S Fujimura, et al.: Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg. 116: 407-411, 1998.
      • C Konaka, N Ikeda, T Hiyoshi, et al.: Peripheral non-small cell Lung cancers 2.0 cm or less in diameter: Proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 21: 185-191, 1998.
      • H Miura, H Nakamura, O Taira, et al.: Outcome of Patients with early Stage Lung Cancer. Surg Today. 28: 736-739, 1998.
      • M Sagawa, A Sakurada, S Fujimura, et al.: Five-year survivors with resected pN2 non-small cell lung carcinoma. Cancer. 85: 864-868, 1999.
      • H Asamura, H Nakayama, H Kondo, et al.: Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 117(6): 1102-1111, 1999.
      • K Suzuki, K Nagai, J Yoshida, et al.: Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 67(4): 927-932, 1999.
      • K Suzuki, K Nagai, J Yoshida, et al.: The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg. 118(1): 145-153, 1999.
      • K Suzuki, K Nagai, J Yoshida, et al.: Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer. 86(10): 1976-1984, 1999.
      • K Suzuki, T Yokose, T Yoshioka, et al.: Subclassification of Noguchi's type C adenocarcinoma of the lung. Jpn J Lung Cancer (Haigan, in Japanese). 39(1): 3-11, 1999.
      • H Asamura, R Tsuchiya, et al.: Where is the boundary between N1 and N2 stations in lung cancer?: A prognostic significance of N1 lymph node metastasis. Ann. Thorac. Surg 2000. 70: 1839-1846, 2000.
      • H Asamura, K Suzuki, H Kondo, et al.: Where is the boundary between N1 and N2 stations in lung cancer? Ann Thorac Surg. 70(6): 1839-45; discussion 1845-1846, 2000.
      • K Suzuki, K Nagai, J Yoshida, et al.: Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 72(2):352-356, 2001.
      • K Suzuki, H Asamura, M Kusumoto, et al.: "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg. 74(5):1635-1639, 2002.
      • M Okada, W Nishio, T Sakamoto, et al.: Long-term survival and prognostic factors of 5-year survivorswith complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 126(2): 558-562, 2003.
      • M Okada, T Sakamoto, W Nishio, et al.: Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer. 98(3): 535-541, 2003.
      • M Okada, W Nishio, T Sakamoto, et al.: Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg. 76: 1828-1832, 2003.
      • K Kubota, Y Ichinose, et al.: Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group. J Clin Oncol. 22(2): 254-261, 2004.
      • M Okada, W Nishio, T Sakamoto, et al.: Correlation between computed tomographic findings, bronchioloalveolar carcinoma component and the biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg. 127: 857-861, 2004.
      • M Okada, W Nishio, T Sakamoto, et al.: Evolution of surgical outcomes for non-small cell lung cancer: Time trends in 1465 consecutive patients subjected to a complete resection. Ann Thorac Surg. 77: 1926-1930, 2004.
      • H Nakamura, H Saji, H Kato, et al.: Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection, Lung Cancer. 44(1): 61-68, 2004.
      • N Ikeda, M Tsuboi, H Kato, et al.: A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter, Ann. of Thoracic Surgery. 78(3): 1011-1016, 2004.
      • H Nakamura, Y Kato, H Kato: Outcome of surgery for small lung cancer-response to induction chemotherapy predicts survival, Thoracic Cardiovascular Surgery. 9(5): 378-382, 2004.
      • S Watanabe, H Asamura, K Suzuki, et al.: Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg. 78(3): 999-1002; discussion 1002-1003, 2004.
      • Y Oshiro, M Kusumoto, Y Matusno, et al.: CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR. 182: 87-91, 2004.
      • H Sakurai, H Asamura, S Watanabe, et al.: Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann Thorac Surg. 78: 222-227, 2004.
      • M Okada, W Nishio, T Sakamoto, et al.: Effect of tumor size on prognosis in non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 129(1): 87-93, 2005.
      • S Watanabe, H Asamura, K Suzuki, et al.: Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg. 79(5): 1682-1685, 2005.
      • H Asamura, T Kameya, Y Matsuno, et al.: Prognostic Spectrum of Pulmonary Neuroendocrine Neoplasms, J Clin Oncol, in press, 2005.
      • T Hirano, H Kato, J Maeda, et al.: Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker. Int J Cancer. 117: 460-468, 2005.
      • M Okada, T Sakamoto, Tsuyoshi, et al.: Hybrid surgical approach of video-assisted minithoracotomy for lung cancer. Chest. 128: 2696-2701, 2005.
      • H Harada, M Okada, T Sakamoto, et al.: Functional advantage following radical segmentectomy over lobectomy for lung cancer. Ann Thorac Surg. 80: 2041-2045, 2005.
      • T Goya, H Asamura, H Kato, et al.: Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study. Lung Cancer. 50:227-234, 2005.
      • M Okada, T Sakamoto, et al.: Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 81: 1028-1032, 2006.
      • J Nagano, Y Ichinose, et al.: A Prospective Japanese Study of the Association between Personality and the Progression of Lung Cancer. Intern Med. 45:57-63, 2006.
      • H Asamura, H Tada, et al.: Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. Jan 1 24(1): 70-76, 2006.
      • K Suzuki, Tsuchiya, H Asamura, et al.: Radiologic classification of small adenocarcinoma of the lung: radiologic- pathologic correlation and its prognostic impact. Ann Thorac Surg. 81: 413-419, 2006.
      • H Asamura, T Goya, T Koshiishi, et al.: How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg. 132:316-319,2006.
      • H Asamura: Treatment of choice for stage I non-small cell lung cancer: surgery orradiotherapy? J Thorac Oncol. 1:766-777, 2006.
      • Y Ichinose: A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan. Cancer Chemother Pharmacol. 58 Suppl 7:43-48, 2006.
    4. 総説・解説
      • HI Pass, H Kato, DA Cortese, et al.: LUNG CANCER (The Use of Light for the Early Detection and Treatment of Lung Cancer). Lippincott William & Wilkins. 425-437, 2000.
      • RJ Korst, R Tsuchiya, et al.: 11,Treatment of non-small cell lung cancer; 11.1, Treatment of NSCLC: Radiotherpy. Textbook of Lung Cancer, 2000.
      • 多田弘人:非小細胞肺癌の術前治療. 肺癌の臨床. 4(1):43-47, 2001.
      • 多田弘人:標準的治療と今後の有望な治療法-これが今の, 5年後のEBMだ!-限局型小細胞肺癌. Medical Practice. 19:107-110, 2002.
      • 奥仲哲弥, 加藤治文: Sentinel node navigation surgeryの現状と展開 5.各臓器におけるSNNSの現状とその成績 c.肺癌. 日本外科学会雑誌. 104(11): 778-780, 2003.
      • H Kato, H Nakamura, M Tsuboi, et al.: Treatment of Peripheral Early Stage Lung Cancer, Ann. of Thoracic and Cardiovascular Surgery. 10(1): 1-3, 2004.
      • 遠藤秀紀, 光冨徹哉:肺癌診断の最前線 遺伝子診断. 呼吸器科. 6: 251-257, 2004.
      • 加藤治文:ガイドラインからみた肺癌外科の構築 1.特集によせて(JCOGの試み). 日本外科学会雑誌. 105(7):387, 2004.
      • 池田徳彦, 坪井正博, 加藤治文:ガイドラインからみた肺癌外科の構築 4.リンパ節転移を伴う肺癌の治療ガイドライン. 日本外科学会雑誌. 105(7): 404-407, 2004.
      • 坪井正博, 加藤治文:肺癌の拡大手術と縮小手術-その評価と展望2.非小細胞肺癌拡大手術の適応, 日本外科学会雑誌. 106(6): 367-374, 2005.
      • S Tomida, T Mitsudomi, et al.: Throwing new light on lung cancer pathogenesis: Updates on three recent topics. Cancer Sci. 96: 63-68, 2005.
      • H Kato, M Tsuboi, Y Kato, et al.: Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer, Int. J Clinical Oncology. 10: 157-164, 2005.
      • 坪井正博, 加藤治文: 非小細胞肺癌の術後補助化学療法の現状と展望. 篠原出版新社・MOOK2004-2005「肺癌の臨床」. 223-230, 2005.
      • 坪井正博, 加藤治文, 奥仲哲弥: 非小細胞肺がんの術後adjuvant療法. 中外医学社・癌化学療法のupdate. 408-414, 2005.
      • 大平達夫, 加藤治文: 非小細胞肺癌 IA期に対する標準的手術は?. 中外医学社・EBM呼吸器疾患の治療2006-2007. 413-415, 2005.
      • 加藤治文: 臨床医学の展望:呼吸器外科学. 日本医事新報. 4216, 37-46, 2005.
      • 雪上晴弘, 光冨徹哉: 肺癌に対する低侵襲外科手術の現状と進歩. Pharma Medica. 23: 23-27, 2005.
      • 森正一, 光冨徹哉: 肺癌の手術療法. コンセンサス癌治療. へるす出版. 4(4): 186-189, 2005.
      • 岡田守人: 再ミニ開胸(VATS)による区域切除. 肺癌. 45: 261-266, 2005.
      • 岡田守人: 呼吸器外科手術の基礎知識 -肺癌に対する拡大手術- 呼吸器ケア. 3: 77-81, 2005.
      • 岡田守人: 増え続ける肺癌/治療成績を向上させるために 末梢小型肺癌に対するアプローチ. 外科治療. 93: 421-426, 2005.
      • 岡田守人, 坪田紀明: 肺癌拡大区域切除の成績と適応. 日本外科学会雑誌. 106: 395-399, 2005.
      • 一瀬幸人: UFTを用いた術後補助化学療法. 肺癌. 45:801-803, 2005.
      • 岡本龍郎, 一瀬幸人: 【肺癌診断・治療の最新情報】 非小細胞肺癌の術後化学療法. 癌と化学療法. 32:765-769, 2005.
      • 岡本龍郎, 一瀬幸人: 【早期非小細胞肺がんに対する最新治療動向】 術前導入療法. 呼吸器科. 7:107-111, 2005.
      • 一瀬幸人: 治療の進歩 非小細胞肺癌術後化学療法の再評価. Annual Review呼吸器. 238-243, 2005.
      • 多田弘人: 特集臨床腫瘍学の現状と展望 V.がん薬物療法の実際 1.肺癌 3)術後のアジュバント療法. Progress in Medicine. 25(8): 61(2043)-65(2047), 2005.
      • 多田弘人: 6.III期非小細胞肺癌の治療 (2)外科の立場から, コンセンサス癌治療. 4(4): 200-203, 2005.
      • 多田弘人: 非小細胞肺癌に対する術前治療, MOOK肺癌の臨床2004-2005 疫学 発見 診断 治療. 篠原出版新社. 215-221, 2005.
      • T Ohira, H Kato, et al.: Early-stage lung cancer: diagnosis and treatment, International Journal of Clinical Oncology. 11(1):9-12, 2006.
      • 岡田守人: 小型肺がんに対する区域切除. Annual Review 呼吸器 2006. 238-243, 2006.
      • 丸山理一郎, 岡本龍郎, 一瀬幸人: 【使用する立場からみた「癌診療ガイドライン」のポイント】 肺癌診療ガイドライン. 外科治療. 94:170-178, 2006.
      • 坪井正博, 加藤治文:Adjuvant and Neoadjuvant Chemotherapy 肺癌. Mebio Oncology. 3(4): 13-19, 2006.
      • 多田弘人: 早期非小細胞肺癌の術後補助化学療法. 最新医学. 61(11): 35-39, 2006.
      • 一瀬幸人: 非小細胞肺がん-Early stage-. In: Key Trial [がん]: 先端医学社. 2006.
      • 一瀬幸人: VIII.治療各論 [A]非小細胞肺癌の治療の実際 ②切除可能症例における集学的治療2.術前治療 治療法の選択にあたって. 工藤翔二(監修). 江口研二, 横井香平, 弦間昭彦(編集). 呼吸器common diseaseの診療 肺癌のすべて. 分光堂. 306-307, 2006.
      • 岡本龍郎, 一瀬幸人: 特集/Adjuvant Chemotherapyno動向. 肺癌におけるAdjuvant chemotherapyの動向. Focus on Oncology. 5:4-7, 2006.
      • 岡本龍郎, 一瀬幸人: 肺癌の術後化学療法の現状と問題. 癌と化学療法. 33:1985-1990, 2006.
      • 加藤治文, 田中浩一, 木下孔明:非小細胞肺癌に対するAdjuvant Chemotherapy. Focus on Oncology 6: 5-7, 2007.
      • 山崎宏司, 一瀬幸人: 肺がん患者への術後補助化学療法をめぐって. 臨床腫瘍プラクティス. 3:219-224, 2007.
      • K Nagai, et al.: Postoperative mortality in lung cancer patients. Ann Thorac cardiovasc Surg. 13:373-375, 2007.
      • 多田弘人: 非小細胞肺癌-補助療法の考え方は?. EBM呼吸器疾患の治療.中外医学社. 323-326, 2007.
      • 多田弘人: 縦隔鏡検査. MOOK肺癌の臨床2008~2009. 篠原出版社. 137-140, 2008.
      • H Asamura, S Watanabe.: In response to the review article in Surgery Today: JCOG trials for small adenocarcinomas of the lung. Surg Today. 44(8):1593-1594, 2014.
      • K Suzuki, S Watanabe, J Mizusawa, et al.: Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study. Interact Cardiovasc Thorac Surg. 21(2): 218-223, 2015.
      • K Nakagawa, S Watanabe, H Kunitoh, et al.: The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: past activities, current status and future direction. Jpn J Clin Oncol. 47(3):194-199, 2017.
      • K Aokage, J Yoshida, T Hishida, et al.: Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol. 47(1):7-11, 2017.
      • S Watanabe, K Nakagawa, K Suzuki, et al.: Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer. Jpn J Clin Oncol. 47(12): 1112-1118, 2017.
  2. 主な学会発表
    1. 委員会承認の治療研究
      JCOG8601
      M Ohta, R Tsuchiya, M Shimoyama, et al.: Adjuvant Chemotherapy for Completely Resected Stage III Non-small-cell Lung Cancer. 6th World Congress on Lung Cancer. Nov 1991.
      JCOG9101
      R Tsuchiya, Y Watanabe, T Yasumitsu, et al.: Surgery & adjuvant chemotherapy (CT) for small cell lung cancer (SCLC). 8th World Congress on Lung Cancer. Aug 1997.
      中川勝裕, 小池輝明, 永井完治,他:肺小細胞癌(病理病期I, II, IIIA)に対する術後化学療法, 第II相試験. 第41回日本肺癌学会総会. 2000年11月.
      K Suzuki, R Tsuchiya, Y Ichinose, et al.: Phase II Trial of Postoperative Adjuvant Cisplatin and Etoposide in Patients with Completely Resected Stage I - IIIa Small Cell Lung Cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). Proceedings of ASCO. 19:492a, 2000.
      JCOG9304
      小池輝明, 多田弘人, 一瀬幸人, 他:N2肺非小細胞がんに対する術後化学療法の比較試験. 第41回日本肺癌学会総会. 2000年11月.
      Y Ichinose, H Tada, T Koike, et al.: A randomized phase III trial of postoperative adjuvant chemotherapy in patients with completely resected stage IIIa-n2 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG 9304) trial. 37th Annual Meeting of the American Society of Clinical Oncology. May 2001.
      光冨徹哉, 谷田部恭, 多田弘人, 他:多施設共同臨床試験における分子マーカーの意義(JCOG9304付随研究). 第42回日本肺癌学会総会. 2001年11月.
      T Mitsudomi, Y Yatabe, H Tada, et al.: Lack of predictive value of p53, p27, Bcl2, HER2/neu, EGFR alterations for efficacy of postoperative adjuvant chemotherapy consisting of cisplatin plus vindesine in patients with non-small cell lung cancer with mediastinal node invovement (JCOG9304A). In: Annual Meeting of the American Society of Clinical Oncology. May 2003.
      JCOG9805
      H Kunitoh, N Saijo, H Tada, et al.: A Pilot Trial of Preoperative MVP-Combined Chemoradiotherapy: Mitomycin C (mmc), Vindesine (VDS), and Cisplatin (CDDP), Concurrentry Given with Thoracic Radiotherapy (TRT) in N2 Non-Small Cell Lung Cancer (NSCLC). 36th Annual Meeting of the American Society of Clinical Oncology. May 2000.
      JCOG9806
      H Kunitoh, H Kato, et al.: A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in pancoast tumors. Initial report of Japan Clinical Oncology Group Trial (JCOG 9806). Thirty-Ninth Annual Meeting of the American Society of Clinical Oncology. May 2003.
      M Tsuboi, H Kato, et al.: A Phase II Trial of pre-operative chemoradiotherapy followed by surgery in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG9806). 10th World Conference on Lung Cancer, Aug 2003.
      Y Ichinose, H Kunitoh, H Kato, et al.: A phase II trial of chemoradiotherapy followed by surgery in Pancoast tumors: initial report of the Japan Clinical Oncology Group trial (JCOG 9806). ECCO12. Sep 2003.
      K Suzuki, H Kunitoh, Y Ichinose, et al.: Phase II trial of preoperative chemoradiotherapy for superior sulcus tumor. JCOG 9806. 11th World Conference on Lung Cancer, 2005.
      JCOG0201
      K Suzuki, T Koike, T Shibata, et al.: Evaluation of radiologic diagnosis in peripheral clinical IA lung cancers--A prospective study for radiological diagnosis of peripheral early lung cancer (JCOG 0201). 42nd Annual Meeting of the American Society of Clinical Oncology.Jun 2006.
      小池輝明, 鈴木健司, 淺村尚生, 他:胸部薄切CT所見に基づく肺野型早期肺癌の診断とその妥当性に関する前向き研究(JCOG0201). 第47回日本肺癌学会総会. 2006年12月.
      JCOG0201A
      K Aokage, K Suzuki, M Wakabayashi, et al.: Development and external validation of a prediction model of pathological lymph node metastasis in lung adenocarcinoma with clinical stage IA and dominant solid part (JCOG0201A): Ancillary analysis of Japan Clinical Oncology Groups trial, JCOG0201. The AATS 98th Annual Meeting. May 2018.
      JCOG0204
      H Tada, H Katoh, H Kunitoh, et al.: A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204). 11th World Conference on Lung Cancer. Jul 2005.
      JCOG0802
      青木 正、鈴木健司、佐治 久、他:肺野末梢小型非小細胞肺癌に対する区域切除と肺葉切除の安全性に関する検討-JCOG0802/WJOG4607Lより-.第58回日本肺癌学会学術集会.2017年10月.
      K Suzuki, H Saji, S Watanabe, et al.: Comparison of Morbidity of Pulmonary Segmentectomy and Lobectomy: Initial Results of a Phase III Randomized Trial of Lobectomy versus Segmentectomy for Small (2 cm or Less) Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L). American Association for Thoracic Surgery. Centennial. Apr 2017.
      JCOG0804
      中川加寿夫、鈴木健司、若林将史、他:肺野型早期肺癌に対する縮小切除の有用性に関する検証的試験(JCOG0804/WJOG4507L).第35回日本呼吸器外科学会総会.2018年5月.
      K Suzuki, S Watanabe, M Wakabayashi, et al.: A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography (JCOG0804/WJOG4507L). 53rd Annual Meeting of the American Society of Clinical Oncology. Jun 2017.
      JCOG1211
      青景圭樹、 佐治久、 鈴木健司、 他:胸部薄切CT所見に基づくすりガラス影優位のcT1N0肺癌に対する区域切除の非ランダム化検証的試験-JCOG1211-. 第33回日本呼吸器外科学会総会. 2016年5月.
      JCOG0707
      H Sakurai, H Kunitoh, M Tsuboi, et al.: Safety and compliance data of the phase III study of adjuvant chemotherapy in completely resected pathological stage I (T1>2cm) non-small cell lung cancer (JCOG0707). 17th World Conference on Lung Cancer. Dec 2016.
      H Kunitoh, M Tsuboi, H Sakurai, et al.: Safety and compliance data of the phase III study of adjuvant chemotherapy for the patients (pts) with completely resected, pathological (p-) stage I (T1> 2 cm) non-small cell lung cancer (JCOG0707). 52nd Annual Meeting of the American Society of Clinical Oncology. Jun 2016.
    2. グループ代表者管理の治療研究
      • 佐川元保, 小池輝明, 佐藤雅美, 他:胸部X線無所見肺扁平上皮癌に対する区域切除術-JCOG肺がん外科グループ. 第40回日本呼吸器学会総会. 2000年3月.
      • 一瀬幸人, 加藤治文, 小池輝明, 他:完全切除IIIAN2非小細胞肺癌例の予後-JCOG肺がん外科グループにおける406例の解析結果-. 第53回日本胸部外科学会総会. 2000年10月.
      • M Tsuboi, Y Ichinose, H Kato, et al.: Overall Survival and Local Recurrence after complete surgical resection with standard lymph node dessecion in cases of pN2 Non-Small Cell Lung Cancer. The Second International Workshop on Surgical Exploration of the Mediastinum and Systemic Nodal Dissection. Nov 2000.
      • 一瀬幸人, 加藤治文, 小池輝明, 他:完全切除IIIAN2非小細胞肺癌における原発巣の部位と転移リンパ節station数の重要性. 第54回日本胸部外科学会総会. 2001年10月.
      • M Tsuboi, H Kato, N Saijo: Japanese trial in resectable lung cancer. Fourth Congress on Lung Cancer. Nov 2001.
      • H Asamura, T Kameya, Y Matsuno, et al.: Prognostic Spectrum of Pulmonary Neuroendocrine Neoplasms, J Clin Oncol, in press, 2005.
      • 坪井正博, 加藤治文: 肺がん外科におけるRCTの問題点. 第105回日本外科学会定期学術集会シンポジウム.・2006年5月.
      • M Tsuboi, H Kato, Y Ichinose, et al.: The influence of tumor size, histological differentiation and smoking history in patients with completely resected stage I adenocarcinoma of the lung. 42nd ASCO Annual Meeting. Jun 2006.
    3. 附随研究等
      • K Suzuki, K Nagai, et al.: Clinical predictors of pathological N2 disease in CT negative NSCLC. Proceedings of ASCO (34th ASCO), 1998.
      • K Suzuki, K Nagai, et al.: Clinical predictors of extrathoracic metastases in clinical T1-2 N0 non-small cell lung cancer patients: Indications for systemic preoperative metastases investigation. Proceedings of ASCO (35th ASCO). 1999.
      • K Suzuki, H Asamura, H Kondo, et al.: Clinical predictors of minimally invasive peripheral adenocarcinoma of the lung: Possible indications for limited surgical resection. Lung Cancer 29(S1): 142. 9th World Conference on Lung Cancer, 2000.
      • Y Ichinose: Symposium: Japanese trials of neoadjuvant treatment for N2 non-small cell lung cancer. 9th World Conference on Lung Cancer. Sep 2000.
      • M Saito, C Konaka, H Kato, et al.: Lymph node status of small lung cancers: 2.0 cm or less in size. 9th World Conference on Lung Cancer. Sep 2000.
      • M Saito, C Konaka, H Kato, et al.: Prognostic factors and nodular status of radical systemic mediastinal lymphadenectomy in patients of pN2 non-small cell lung cancer. 9th World Conference on Lung Cancer. Sep 2000.
      • N Ikeda, T Ohira, T Hirano, et al.: The possibility of clinical application of Malignancy Associated Changes for early detection of lung cancer. Third International Conference on Prevention and Early Detection of Lung Cancer. Aug 2001.
      • H Tada, T Yasumitsu, K Iuchi, et al.: Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: lack of prognostic significance in DNA ploidy pattern at adjuvant setting. 38th Annual Meeting of the American Society of Clinical Oncology. May 2002.
      • 林 明男, 多田弘人, 山本良二, 他: IIIA期N2非小細胞肺癌に対する, 術前化学療法+縦隔のみの同時併用放射線療法の施行例の検討. 第76回日本肺癌学会関西支部会. 2002年8月.
      • 多田弘人, 山本良二, 東条 尚, 他: cN2 非小細胞肺癌に対する術前化学療法と放射線併用療法の違いについて. 第55回 日本胸部外科学会総会. 2002年10月.
      • T Tojo, H Tada, R Yamamoto, et al.: CTfindings of Large Cell Neuroendocrine Carcinoma. CHEST. Nov 2002.
      • 杦浦孝宗, 武田晃司, 尾崎智博, 他:CT画像上Ground Glass Attenuation(GGA)を呈する末梢型早期肺癌の検討. 第43回日本肺癌学会総会. 2002年11月.
      • 多田弘人, 山本良二, 東条 尚, 他:肺癌の切除成績の向上はbiasによるものである. 第20回日本呼吸器外科学会総会. 2003年5月.
      • Y Ichinose, T Seto, H Yamamoto, et al.: Intrapleural hypotonic cisplatin treatment (HPT) for malignant pleural effusion in 80 patients with non-small cell lung cancer (NSCLC). 39th Annual Meeting of the American Society of Clinical Oncology. May 2003.
      • M Tsuboi, H Kato, et al.: A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological Stage I (T1N0M0, T2N0M0) adenocarcinoma of the Lung. Thirty-Ninth Annual Meeting of the American Society of Clinical Oncology. May 2003.
      • Y Ichinose, Y Fukuyama, H Asoh, et al.: Induction Chemoradiotherapy and Surgical Resection for Selected Stage IIIB Non-Small Cell Lung Cancer. 10th World Conference on Lung Cancer. Aug 2003.
      • H Tada, T Yasumitsu, K Iuchi, et al.: Randomized control study of adjuvant chemotherapy with UFT alone or plus cisplatin and vindesine in patients with completely resected Non-small cell lung cancer. 10th World Conference on Lung Cancer. Aug 2003.
      • K Suzuki, K Nagai, et al.: Clinical predictors of postoperative brain metastasis in lung cancer. Proceedings of ASCO (37th ASCO), 2001.
      • M Okada, K Uchino, T Sakamoto, et al.: Discrepancy of computed tomography images between lung and mediastinal windows as a prognostic significance in small-sized lung adenocarcinoma . CHEST2003; Annual International Scientific Assembly of the American College of Chest Physician. Oct 2003.
      • K Suzuki: Combined modality for N2 NSCLC. Risk for right side pneumonectomy. 9th Central European Lung Cancer Conference, 2003.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他: 根治性とQuality of lifeの維持を追求した肺癌手術の進化 -原発性肺癌手術1788例の検討-. 第20回日本呼吸器外科学会総会. 2003年5月.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他: Long-term survival and prognostic factors of 5-year survivors with complete resection of non-small cell lung carcinoma. 第103回日本外科学会総会. 2003年6月.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他: 積極的縮小手術適応基準の模索;術前CT画像のGGOとTDRは切除標本のBACを如何に反映するか. 第56回日本胸部外科学会総会. 2003年11月.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他:局所進行肺癌に対する集学的治療における手術の安全性;Induction therapyは術後合併症のリスクを増大させるか. 第56回日本胸部外科学会総会. 2003年11月.
      • Y Ichinose: Special recture: A step forward to the treatment of lung cancer. The 36th Annual Congress of the Korean Society for Thoracic and Cardiovascular Surgery. Nov 2004.
      • Y Ichinose: Special Lecture: Current status and perspective of postoperative adjuvant chemotherapy in completely resected non-small cell lung cancer patients. The 2004 Annual Meeting of Taiwan Society of Pulmonary and Critical Care Medicine. Dec 2004.
      • R Yamamoto, T Tojo, H Tada, et al.: Prognosis of stage I non-small cell lung cancer patients with positive pleural lavage cytology. CHEST. Oct 2004.
      • 一瀬幸人:シンポジウム:進行肺癌に対す治療戦略:臨床病期IIIB期非小細胞肺癌に対する集学的治療:Bimodality treatmentと手術を含むtrimodality treat mentの第II相試験. 第104回日本外科学会. 2004年4月.
      • 一瀬幸人:ランチョンセミナー:非小細胞肺癌治療の現況と展望. 第45回臨床細胞学会総会. 2004年4月.
      • 一瀬幸人:教育講演5「非小細胞肺癌の集学的治療」:UFTを用いた術後補助化学療法. 第45回日本肺癌学会総会. 2004年4月.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他:肺癌に対する内視鏡手術の光と影. 第21回日本呼吸器外科学会総会. 2004年5月.
      • 岡田守人:ミニ開胸またはVATSによる区域切除. 第19回日本肺癌学会肺癌ワークショップ. 2004年7月.
      • 岡田守人, 西尾 渉, 阪本俊彦, 他:腫瘍径からみた肺癌に対する術式選択の妥当性. 第57回日本胸部外科学会総会. 2004年10月.
      • 中嶋 隆, 東条 尚, 多田弘人, 他:IIIA期非小細胞肺癌に対する術前化学療法と縦隔照射による multimodality treatment の検討. 第79回 日本肺癌学会関西支部会. 2004年2月.
      • 多田弘人, 出口 寛, 中嶋 隆, 他:局所進行肺癌の治療戦略. 第21回日本呼吸器外科学会総会. 2004年5月.
      • 多田弘人:肺癌外科におけるEBM. 第45回日本肺癌学会総会. 2004年10月.
      • Y Ichinose: Surgery and Adjuvant Chemotherapy: The Japanese Experience. 11th World Conference on Lung Cancer. Jul 2005.
      • 岡田守人, 阪本俊彦, 湯木 毅, 他:肺癌に対するミニ開胸を併用した胸腔鏡下手術の成績. 第105回日本外科学会総会. 2005年5月.
      • 吉田純司, 永井完治, 西村光世, 他:肺野末梢小型肺腺癌に対する縮小手術プロトコール研究. 第105回日本外科学会定期学術集会. 2005年5月.
      • 多田弘人:肺癌におけるリンパ筋郭清の意義. 第45回日本呼吸器学会学術講演会. 2005年4月.
      • 福岡正博, 國頭英夫, 多田弘人:非小細胞肺癌完全切除後アジュバント化学療法は標準か?. 第45回日本呼吸器学会学術講演会. 2005年4月.
      • 福原謙二郎, 多田弘人, 山本良二, 他: c-N1非小細胞肺癌切除例の検討. 第22回日本呼吸器外科学会総会. 2005年6月.
      • 中嶋隆, 多田弘人, 加藤治文, 他:原発性肺癌術後再発治療:方針の変化と予後. 第22回 日本呼吸器外科学会総会. 2005年6月.
      • 大和 靖, 小池輝明, 吉谷克雄, 他: pN2非小細胞肺癌完全切除例の予後因子に関する多施設共同研究. 第46回日本肺癌学会. 2005年11月.
      • 岡田守人: 合理的縦隔リンパ節郭清の長期成績. 第58回日本胸部外科学会総会(シンポジウム). 2005年10月.
      • 岡田守人: 早期小型肺癌が激増する時代における腫瘍径2cmでのI期分類の妥当性. 第46回日本肺癌学会総会(シンポジウム). 2005年11月.
      • 永井完治, 吉田純司, 他: 2cm以下T1N0M0 NSCLCに対する手術様式. 本胸部外科学会定期学術集会. 2005年10月.
      • M Tsuboi, T Ohira, H Kato, et al.: Surgical outcome for the subcentimeter lung cancer; Is the sublobular resection an emerging concept in this population? 4th EACTS/ESTS Joint meeting. Sep 2005.
      • M Tsuboi, T Ohira, H Kato, et al.: Preoperative induction chemotherapy with weekly paclitaxel and carboplatin for clinical-stage IB-IIIA non-small cell lung cancer. 11th World Conference on Lung cancer. Jul 2005.
      • Y Ichinose: A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan. The 21st Program Kurume University Graduate School of Medicine, Research Center for Innovative Cancer Therapy. Nov 2005.
      • K Goto, Y Ichinose, et al.: The Four-Arm Cooperative Study (FACS) for advanced non-small cell lung cancer (NSCLC): A subgroup analysis in elderly patients (pts). 42nd ASCO Annual Meeting. Jun 2006.
      • M Tsuboi, H Kato, Y Ichinose, et al.: the Japan Lung Cancer Research Group on Postsurgic: The influence of tumor size, histological differentiation and smoking history in patients with completely resected stage I adenocarcinoma of the lung. 42nd Annual Meeting of the American Society of Clinical Oncology. Jun 2006.
      • 多田弘人: 非小細胞肺癌における術後補助化学療法のありかた.第29回 日本呼吸器内視鏡学会学術集会. 2006年6月.
      • M Tsuboi, H Kato, Y Ichinose, et al.: Japan Lung Cancer Research Group: Why did the gender difference influence survival in patients with completely resected stage I adenocarcinoma of the lung? 43rd ASCO Annual Meeting. Jun 2007.
      • 多田弘人: N2非小細胞肺癌に対する手術の意義. 第47回日本呼吸器学会学術講演会. 2007年5月.
      • 多田弘人: 術前治療の問題点.第32回日本外科系連合学会学術集会. 2007年6月.
      • H Tada: Advancement of surgery for non-small cell lung cancer.12th World Conference on Lung Cancer. Sep 2007.
      • T Sawa, K Eguchi, T Ishigur, et al.: Japanese multidisciplinary medical care guideline for patients with lung cancer by non-profit organization of multi-institutional study group (WJTOG). 12th World Conference on Lung Cancer. Sep 2007.
    4. 総説・解説
      • H Kato: Novel Methods for Treatment of Early Lung Cancer. IASLC 3rd International Conference on Prevention and Early Detection of Lung Cancer. Aug 2001.
      • H Kato, M Tsuboi: Early Lung Cancer: World Ongoing Trials, Japan, Screening of Lung, Cancer, early localization and treatent. International Symposium on Lung Cancer. Sep 2001.
      • H Kato, M Tsuboi: Adjuvant Therapy for Early Stage NSCLC. The Second International Chicago Symposium on Malignancies of the Chest and Head & Neck. Oct 2001.
      • 一瀬幸人, 加藤治文, 小池輝明, 他:ワークショップ「外科におけるrandomized controlled trial」:Japan Clinical Oncology Group(JCOG)肺がん外科グループにおけるrandomized controlled trial. 第102回日本外科学会総会. 2002年4月.
      • H Kato: Early localization of sputum detected lung cancer, The 11th International conference on Screening for Lung Cancer. Oct 2004.
      • H Kato: Adjuvant chemotherapy with UFT for resected NSCLC, IASLC Workshop. Oct 2004.
      • H Kato: The postoperative adjuvant trials with UFI for p-stage 1 non-small cell lung cancer, The 42nd Annual Meeting of Japan Society of Clinical Oncology. Oct 2004.
      • K Suzuki: Management of CT detected lung nodules. Hot topics. 2005 11th World Conference on Lung Cancer. 2005.
      • M Tsuboi, H Kato: The new technologies for the diagnosis and therapy of lung cancer. 14th Panhellenic Congress on Thoracic Diseases, Thessaloniki. Dec 2005.
      • H Asamura, M Tsuboi, H Kato: Japanese Clinical Trials; ongoing & closed. 18th annual meeting of General Thoracic Surgical Club. Mar 2005.
      • 加藤治文: 末梢型小型肺癌の診断と治療. 第67回日本臨床外科学会総会. 2005年11月.
      • 坪井正博, 加藤治文: 非小細胞肺癌手術補助療法の戦略;術前化学療法の臨床試験と今後のstudy designを中心に. 第22回日本呼吸器外科学会総会シンポジウム. 2005年6月.
      • 坪井正博, 加藤治文: 非小細胞肺癌術後の補助化学療法は標準治療となったか;「術後病期I期症例に対する治療」. 第43回日本癌治療学会総会ワークショップ. 2005年10月.
      • 坪井正博, 加藤治文: 術後アジュバント治療におけるEGF受容体チロシン・キナーゼ阻害剤. 第20回日本肺癌学会ワークショップ. 2005年7月.
      • 坪井正博, 加藤治文: IB-III期非小細胞肺癌に対する術前化学療法の取組み. 第46回日本肺癌学会総会シンポジウム. 2005年11月.
      • 岡田守人: Hybrid VATS. 第46回日本肺癌学会総会(イーブニングセミナー). 2005年11月.
      • 岡田守人: 区域切除の実際 -Policy & Skill. 第22回日本呼吸器外科学会総会(ランチョンセミナー). 2005年6月.
      • 多田弘人: 特別講演:非小細胞肺癌の術前・術後治療について. 静岡県呼吸器外科医会 第16回集談会. 2005年1月.
      • 多田弘人: シンポジウム:肺癌におけるリンパ筋郭清の意義. 第45回日本呼吸器学会学術講演会. 2005年4月.
      • 福岡正博, 國頭英夫, 多田弘人: プロ・コンセッション:非小細胞肺癌完全切除後アジュバント化学療法は標準か?. 第45回日本呼吸器学会学術講演会. 2005年4月.
      • 吉田純司: 病期IB-II非小細胞肺癌に対する術前化学療法の展望. 第23回日本呼吸器外科学会総会. 2006年5月.
      • 岡田守人: 縮小手術. 第32回日本肺癌学会肺癌診断会(シンポジウム指定発表). 2006年6月.
      • 岡田守人: 肺癌手術の治療成績. 第23回日本呼吸器外科学会総会(ワークショップ). 2006年5月.
      • 加藤治文:喫煙習慣と関連がん(生活習慣曝露):診断と治療について, 平成18年度日本癌学会シンポジウム. 2006年7月.
      • 星川 康, 桜田 晃, 近藤 丘:肺癌診療ガイドラインの利用状況と評価-2003年版の使用状況に関するアンケート集計結果より-.第47回日本肺癌学会総会.2006年12月.
      • H Kato: The present and future photodynamic diagnosis and therapy in pneumology, 11th World Congress of the International Photodynamic Association. Mar 2007.
      • 加藤治文:非小細胞肺がんの補助化学療法についての動向, 第21回冬季札幌がんセミナー. 2007年2月.
      • 遠藤千顕, 近藤 丘:肺癌外科療法のガイドライン. 第48回日本呼吸器学会学術講演会. 2008年6月.
トップへ戻る